TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer
Article in European Journal of Medical Research (February 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer
Preprint in Research Square (January 2024)
Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in bladder cancer
Preprint in Research Square (December 2023)